CARL ZEISS MEDITEC ADR 1 Working Capital to Net Assets Ratio
CARL ZEISS MEDITEC ADR 1 working capital to net assets ratio. CARL ZEISS MEDITEC ADR 1 (AFXA) has a Working Capital to Net Assets ratio of 34.2% as of September 2025. Working capital of €728.13 Million (current assets of €1.27 Billion minus current liabilities of €543.81 Million) is measured against net assets of €2.13 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of CARL ZEISS MEDITEC ADR 1 (2022–2025)
Working capital to net assets ratio of CARL ZEISS MEDITEC ADR 1 from 2022 to 2025. This chart shows how CARL ZEISS MEDITEC ADR 1's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of September 2025, the ratio stands at 34.2%, reflecting working capital of €728.13 Million against net assets of €2.13 Billion EUR. See AFXA defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
CARL ZEISS MEDITEC ADR 1 Working Capital to Net Assets Ratio by Year (2022–2025)
CARL ZEISS MEDITEC ADR 1 working capital to net assets ratio by year from 2022 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for CARL ZEISS MEDITEC ADR 1 from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see CARL ZEISS MEDITEC ADR 1 balance sheet assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 34.2% | €728.13 Million | €2.13 Billion | €1.27 Billion | €543.81 Million | ▲ +3.1 pp |
| 2024 | 31.1% | €639.09 Million | €2.06 Billion | €1.21 Billion | €568.84 Million | ▼ -31.1 pp |
| 2023 | 62.1% | €1.35 Billion | €2.17 Billion | €1.91 Billion | €561.65 Million | ▲ +0.4 pp |
| 2022 | 61.7% | €1.25 Billion | €2.03 Billion | €1.79 Billion | €539.32 Million | — |